Marco C Merlano1, Martino Monteverde2, Ida Colantonio3, Nerina Denaro4, Cristiana Lo Nigro2, Guido Natoli3, Francesco Giurlanda5, Gianmauro Numico6, Elvio Russi7. 1. Dept. of Medical Oncology, S. Croce General Hospital, Cuneo, Italy. Electronic address: mcmerlano@gmail.com. 2. Dept. of Medical Oncology, Translational Oncology Lab, S. Croce General Hospital, Cuneo, Italy. 3. Dept. of Medical Oncology, S. Croce General Hospital, Cuneo, Italy. 4. Dept. of Medical Oncology, S. Croce General Hospital, Cuneo, Italy; Dept. of Human Pathology, Messina University, Italy. 5. Dept. of Medical Oncology, Clinical Trials Office, S. Croce General Hospital, Cuneo, Italy. 6. Dept. of Medical Oncology, Aosta General Hospital, Aosta, Italy. 7. Dept. of Radiation Therapy, S. Croce General Hospital, Cuneo, Italy.
Abstract
INTRODUCTION: The purpose of this study is to retrospectively analyze acute toxicity encountered in young and old patients treated with chemo-radiation or bio-radiation at the S. Croce General Hospital between 1997 and 2008, in daily clinical practice. MATERIAL AND METHODS: Three hundred and seventeen patients were allocated into two groups according to age (cut-off 65 years). The two groups were compared in terms of treatment related toxicities, treatment activity and efficacy. Epidermal Growth factor receptor (EGFr), Human papillomavirus (HPV) and p53 status were also considered. RESULTS: As expected, overall survival was significantly worse in elderly patients (p=0.005), but response rate, including complete response rate, was similar between the two age groups, as were most of the side effects analyzed. However, infections (p=0.011) and in particular pneumonias (p=0.002) were significantly more represented in elderly patients. CONCLUSION: Elderly patients treated with chemo-radiation or bio-radiation in our centre had a higher risk of infection and in particular, pneumonia. These data suggest a more careful follow-up, but age alone does not justify their exclusion from treatment.
INTRODUCTION: The purpose of this study is to retrospectively analyze acute toxicity encountered in young and old patients treated with chemo-radiation or bio-radiation at the S. Croce General Hospital between 1997 and 2008, in daily clinical practice. MATERIAL AND METHODS: Three hundred and seventeen patients were allocated into two groups according to age (cut-off 65 years). The two groups were compared in terms of treatment related toxicities, treatment activity and efficacy. Epidermal Growth factor receptor (EGFr), Human papillomavirus (HPV) and p53 status were also considered. RESULTS: As expected, overall survival was significantly worse in elderly patients (p=0.005), but response rate, including complete response rate, was similar between the two age groups, as were most of the side effects analyzed. However, infections (p=0.011) and in particular pneumonias (p=0.002) were significantly more represented in elderly patients. CONCLUSION: Elderly patients treated with chemo-radiation or bio-radiation in our centre had a higher risk of infection and in particular, pneumonia. These data suggest a more careful follow-up, but age alone does not justify their exclusion from treatment.
Authors: Dustin A Silverman; Chen Lin; Akina Tamaki; Sidharth V Puram; Ricardo L Carrau; Nolan B Seim; Antoine Eskander; James W Rocco; Matthew O Old; Stephen Y Kang Journal: Head Neck Date: 2020-04-30 Impact factor: 3.147
Authors: Tim Müller; Martin Braun; Friedrich Bootz; Peter Brossart; Dimo Dietrich; Seher Aktekin; Simon Höft; Glen Kristiansen; Friederike Göke; Andreas Schröck; Johannes Brägelmann; Stefanie A E Held Journal: Oncotarget Date: 2017-05-02
Authors: Herve Y Sroussi; Joel B Epstein; Rene-Jean Bensadoun; Deborah P Saunders; Rajesh V Lalla; Cesar A Migliorati; Natalie Heaivilin; Zachary S Zumsteg Journal: Cancer Med Date: 2017-10-25 Impact factor: 4.452